Valuation Mega Lifesciences Thailand S.E.

Stocks

End-of-day quote Thailand S.E. 17/08/2026			5-day change	1st Jan Change
37.50 ^THB	-1.32%		-4.46%	+11.94%

08-13	Mega Lifesciences Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-16	Mega Lifesciences Public Company Limited, Q1 2026 Earnings Call, May 14, 2026

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	44,029	40,760	35,093	28,990	29,208	32,695	-	-
Change	-	-7.43%	-13.9%	-17.39%	0.75%	11.94%	-	-
Enterprise Value (EV) ¹	41,666	38,309	32,456	25,464	25,051	28,281	27,969	27,639
Change	-	-8.06%	-15.28%	-21.54%	-1.62%	12.89%	-1.1%	-1.18%
P/E	22.6x	18.2x	17.6x	14.4x	15.3x	13.9x	13.2x	12.4x
PBR	5.5x	4.64x	3.77x	2.94x	2.86x	3.07x	2.95x	2.84x
PEG	-	1.2x	-1.6x	16.49x	-2.95x	0.6x	2.49x	1.9x
Capitalization / Revenue	3.08x	2.6x	2.24x	1.89x	2.06x	2.2x	2.09x	1.99x
EV / Revenue	2.91x	2.44x	2.07x	1.66x	1.77x	1.91x	1.79x	1.68x
EV / EBITDA	17.2x	13x	10.2x	6.78x	8.73x	9.16x	7.93x	7.37x
EV / EBIT	18.1x	14.3x	11.2x	7.56x	9.69x	10.2x	8.81x	8.19x
EV / FCF	16.2x	22.6x	19.6x	11.8x	11.9x	13.7x	12.8x	12.3x
FCF Yield	6.18%	4.42%	5.09%	8.46%	8.41%	7.29%	7.81%	8.16%
Dividend per Share ²	1.06	1.61	1.65	1.6	1.6	1.72	1.894	2.017
Rate of return	2.1%	3.44%	4.1%	4.81%	4.78%	4.59%	5.05%	5.38%
EPS ²	2.23	2.57	2.29	2.31	2.19	2.705	2.849	3.034
Distribution rate	47.5%	62.6%	72.1%	69.3%	73.1%	63.6%	66.5%	66.5%
Net sales ¹	14,301	15,686	15,681	15,344	14,147	14,836	15,614	16,404
EBITDA ¹	2,426	2,953	3,190	3,756	2,868	3,087	3,526	3,750
EBIT ¹	2,305	2,681	2,904	3,370	2,585	2,772	3,176	3,375
Net income ¹	1,947	2,242	1,993	2,012	1,912	2,207	2,483	2,646
Net Debt ¹	-2,363	-2,451	-2,636	-3,525	-4,156	-4,414	-4,726	-5,056
Reference price ²	50.50	46.75	40.25	33.25	33.50	37.50	37.50	37.50
Nbr of stocks (in thousands)	871,870	871,870	871,870	871,870	871,870	871,870	-	-
Announcement Date	23/02/22	25/02/23	22/02/24	24/02/25	24/02/26	-	-	-

¹THB in Million²THB

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	33.76x	12.18x	24.85x	0.59%	1,052B
JOHNSON & JOHNSON	28.96x	-	-	2.06%	627B
ABBVIE INC.	31.84x	7.42x	15.42x	2.75%	441B
ROCHE HOLDING AG	19.79x	4.7x	11.65x	2.81%	349B
NOVARTIS AG	21.42x	5.54x	13.77x	2.89%	287B
ASTRAZENECA PLC	19.89x	4.11x	11.68x	2.14%	241B
AMGEN INC.	26.26x	6.84x	12.14x	2.43%	224B
NOVO NORDISK A/S	13.32x	4.79x	9.96x	3.83%	202B
GILEAD SCIENCES, INC.	-42.28x	6.13x	23.96x	2.38%	172B
Average	17.00x	6.46x	15.43x	2.43%	399.46B
Weighted average by Cap.	24.17x	8.04x	17.73x	2%